Schetz Miet
Department of Intensive Care Medicine, University Hospital Gasthuisberg, Herestraat 49, Leuven 3000, Belgium.
Best Pract Res Clin Anaesthesiol. 2004 Mar;18(1):75-89. doi: 10.1016/j.bpa.2003.09.003.
Because oliguria is a bad prognostic sign in patients with acute renal failure (ARF), diuretics are often used to increase urine output in patients with or at risk of ARF. From a pathophysiological point of view there are several reasons to expect that loop diuretics also could have a beneficial effect on renal function. However, clinical trials on the prophylactic use of loop diuretics rather point to a deleterious effect on parameters of kidney function. In patients with established ARF loop diuretics have been shown to increase urine output, which may facilitate patient management. A beneficial effect on renal function has, however, not been demonstrated. On the other hand, such an effect cannot be excluded because the available trials lack statistical power. Possible explanations for the absence of a renoprotective effect are discussed. The evidence for a renoprotective effect of mannitol is restricted to the setting of renal transplantation.
由于少尿是急性肾衰竭(ARF)患者预后不良的征兆,利尿剂常被用于增加ARF患者或有ARF风险患者的尿量。从病理生理学角度来看,有几个原因可以预期袢利尿剂对肾功能也可能有有益作用。然而,关于预防性使用袢利尿剂的临床试验反而表明其对肾功能参数有有害影响。在已确诊的ARF患者中,袢利尿剂已被证明可增加尿量,这可能便于患者管理。然而,其对肾功能的有益作用尚未得到证实。另一方面,由于现有试验缺乏统计学效力,这种作用也不能排除。文中讨论了缺乏肾脏保护作用的可能原因。甘露醇具有肾脏保护作用的证据仅限于肾移植情况。